Problem 1 - Brenner and Stevens’ Pharmacology

Question

A patient takes nateglinide before each meal. Which mechanism is responsible for the therapeutic effect of this drug? (A) closing of potassium channels (B) slowed gastric emptying (C) inhibition of \(\alpha\)-glucosidase (D) inhibition of DPP-4 (E) insertion of glucose transporters in cell membranes

Step-by-Step Solution

Answer

The mechanism responsible for nateglinide's effect is the closing of potassium channels (A).

Step 1: Understanding Nateglinide's Function

Nateglinide is an oral medication used to manage blood sugar levels in patients with type 2 diabetes. It belongs to a class of drugs known as meglitinides.

Step 2: Mechanism of Meglitinides

Meglitinides, including nateglinide, work by stimulating the pancreas to release more insulin. This occurs due to their action on certain ion channels in the beta cells of the pancreas.

Step 3: Identifying the Specific Mechanism

The specific mechanism by which meglitinides like nateglinide stimulate insulin release involves the closing of ATP-sensitive potassium channels on pancreatic beta cells. This leads to depolarization of the cell membrane, opening calcium channels and triggering insulin secretion.

Step 4: Selecting the Correct Option

Given the mechanism of action described, the therapeutic effect of nateglinide is achieved through the closing of potassium channels. This corresponds to option A.

Key Concepts

Nateglinide

Nateglinide is a medication often prescribed for managing Type 2 diabetes. It belongs to a group of drugs known as meglitinides, which are used to help the body regulate blood sugar levels effectively. When patients take nateglinide before meals, it aids in controlling post-meal blood sugar spikes. This is particularly important for preventing the long-term complications associated with diabetes, such as damage to blood vessels and nerves.
This drug is taken orally, and its action starts quickly in the body, making it ideal for use before meals.

Type 2 Diabetes Management

Type 2 diabetes is a chronic condition characterized by insulin resistance and impaired insulin secretion. Managing this condition requires a multi-faceted approach that includes lifestyle changes, regular monitoring of blood sugar levels, and often medication.
Patients with Type 2 diabetes can benefit from medications like nateglinide, which specifically target blood sugar levels following meals.

• Diet modifications, such as reducing sugar and carbohydrate intake.
• Regular physical activity to improve insulin sensitivity.
• Monitoring blood sugar regularly to adjust medication and diet appropriately.

By combining medication with lifestyle adjustments, individuals can achieve better control over their diabetes and improve their overall health.

Insulin Secretion

Insulin secretion is a natural process by which the pancreas releases insulin to help manage blood sugar levels in the body. In people without diabetes, insulin helps move glucose from the bloodstream into cells where it can be used for energy.
For those with Type 2 diabetes, this process may be impaired due to insulin resistance or inadequate insulin production. Nateglinide and other similar drugs stimulate the release of insulin by acting on the pancreatic beta cells, which are responsible for producing and releasing insulin.
This efficient stimulating action helps patients with Type 2 diabetes better manage their blood sugar levels, particularly after meals.

Meglitinides

Meglitinides are a class of oral medications used in the treatment of Type 2 diabetes, including drugs like nateglinide and repaglinide. They work by stimulating the pancreas to release insulin rapidly, particularly in response to meal-related blood sugar increases.

• Designed for quick onset and short duration of action.
• Useful for managing blood sugar levels after meals.
• Can be taken just before eating, making them convenient for managing mealtimes.

These properties make meglitinides beneficial for patients who need to manage their blood sugar levels around meal times without experiencing long-term side effects.

Pancreatic Beta Cells

Pancreatic beta cells are specialized cells located in the islets of Langerhans within the pancreas. They play a critical role in regulating blood sugar by producing and secreting insulin. In healthy individuals, beta cells respond to increases in blood glucose levels by releasing insulin, which helps cells throughout the body absorb glucose.
In the context of Type 2 diabetes, beta cells may not function properly due to insulin resistance or other factors.
Nateglinide aids these cells by closing ATP-sensitive potassium channels, leading to depolarization and subsequent insulin release. By focusing on beta cell stimulation, nateglinide helps to ensure efficient insulin secretion, thereby aiding in the management of Type 2 diabetes.